| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 20:49:55 UTC |
|---|
| Update Date | 2021-09-26 22:50:43 UTC |
|---|
| HMDB ID | HMDB0243581 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile |
|---|
| Description | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system. Based on a literature review very few articles have been published on 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile. This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(e)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CCOC1=C(NCC=CCN(C)C)C=C2C(NC3=CC(Cl)=C(OCC4=CC=CC=N4)C=C3)=C(C=NC2=C1)C#N InChI=1S/C30H31ClN6O2/c1-4-38-29-17-26-24(16-27(29)34-13-7-8-14-37(2)3)30(21(18-32)19-35-26)36-22-10-11-28(25(31)15-22)39-20-23-9-5-6-12-33-23/h5-12,15-17,19,34H,4,13-14,20H2,1-3H3,(H,35,36) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C30H31ClN6O2 |
|---|
| Average Molecular Weight | 543.07 |
|---|
| Monoisotopic Molecular Weight | 542.219702 |
|---|
| IUPAC Name | 4-({3-chloro-4-[(pyridin-2-yl)methoxy]phenyl}amino)-6-{[4-(dimethylamino)but-2-en-1-yl]amino}-7-ethoxyquinoline-3-carbonitrile |
|---|
| Traditional Name | 4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-6-{[4-(dimethylamino)but-2-en-1-yl]amino}-7-ethoxyquinoline-3-carbonitrile |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCOC1=C(NCC=CCN(C)C)C=C2C(NC3=CC(Cl)=C(OCC4=CC=CC=N4)C=C3)=C(C=NC2=C1)C#N |
|---|
| InChI Identifier | InChI=1S/C30H31ClN6O2/c1-4-38-29-17-26-24(16-27(29)34-13-7-8-14-37(2)3)30(21(18-32)19-35-26)36-22-10-11-28(25(31)15-22)39-20-23-9-5-6-12-33-23/h5-12,15-17,19,34H,4,13-14,20H2,1-3H3,(H,35,36) |
|---|
| InChI Key | ZNHPZUKZSNBOSQ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Quinolines and derivatives |
|---|
| Sub Class | Aminoquinolines and derivatives |
|---|
| Direct Parent | Aminoquinolines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminoquinoline
- Dihydroquinoline
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- Halobenzene
- Secondary aliphatic/aromatic amine
- Chlorobenzene
- Aryl chloride
- Aryl halide
- Pyridine
- Monocyclic benzene moiety
- Benzenoid
- Heteroaromatic compound
- Secondary ketimine
- Tertiary amine
- Tertiary aliphatic amine
- Azacycle
- Secondary amine
- Ether
- Carbonitrile
- Nitrile
- Organooxygen compound
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Cyanide
- Organohalogen compound
- Organochloride
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.618 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.66 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1002.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 187.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 158.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 176.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 73.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 333.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 451.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 824.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 836.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 59.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 868.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 211.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 299.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 387.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 478.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C | 4501.4 | Semi standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C | 3937.2 | Standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C | 5931.0 | Standard polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C)=C2C=C1NCC=CCN(C)C | 4415.3 | Semi standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C)=C2C=C1NCC=CCN(C)C | 3923.5 | Standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C)=C2C=C1NCC=CCN(C)C | 5849.0 | Standard polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,2TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C | 4226.7 | Semi standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,2TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C | 3537.0 | Standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,2TMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C | 5507.6 | Standard polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C(C)(C)C | 4644.4 | Semi standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C(C)(C)C | 4136.2 | Standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C(C)(C)C | 5956.7 | Standard polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TBDMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1NCC=CCN(C)C | 4558.4 | Semi standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TBDMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1NCC=CCN(C)C | 4021.8 | Standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,1TBDMS,isomer #2 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1NCC=CCN(C)C | 5857.2 | Standard polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,2TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C(C)(C)C | 4542.8 | Semi standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,2TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C(C)(C)C | 3852.2 | Standard non polar | 33892256 | | 4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-6-[[(E)-4-(dimethylamino)but-2-enyl]amino]-7-ethoxyquinoline-3-carbonitrile,2TBDMS,isomer #1 | CCOC1=CC2=NC=C(C#N)C(N(C3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)[Si](C)(C)C(C)(C)C)=C2C=C1N(CC=CCN(C)C)[Si](C)(C)C(C)(C)C | 5560.8 | Standard polar | 33892256 |
|
|---|